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Abstract 34 
Study design: Experimental study. 35 
Objectives: To characterize static and dynamic cerebral autoregulation (CA) of individuals 36 
with cervical spinal cord injury (SCI) compared to able-bodied controls in response to 37 
moderate increases in mean arterial pressure (MAP) caused by mild whole-body cold stress. 38 
Setting: Japan 39 
Methods: Five men with complete autonomic cervical SCI (sustained>5y) and six age-matched 40 
able-bodied men participated in hemodynamic, temperature, catecholamine and respiratory 41 
measurements for 60 min during three consecutive stages: baseline (10 min; 330C water through a 42 
thin-tubed whole-body suit), mild cold stress (20 min; 250C water) and post-cold recovery (30 43 
min; 330C water). Static CA was determined as the ratio between mean changes in middle 44 
cerebral artery blood velocity and MAP, dynamic CA as transfer function coherence, gain and 45 
phase between spontaneous changes in MAP to middle cerebral artery blood velocity. 46 
Results: MAP increased in both groups during cold and post-cold recovery (mean differences: 47 
5 to 10 mm Hg; main effect of time: p=0.001). Static CA was not different between the able-48 
bodied vs the cervical SCI group (mean [95% CI] of between-group difference: -4 [-11 to 3] 49 
and -2 [-5 to 1] cm/s/mmHg for cold (p=0.22) and post-cold (p=0.24), respectively). At 50 
baseline, transfer function phase was shorter in the cervical SCI group (mean [95% CI] of 51 
between-group difference: 0.6 [0.2 to 1.0] rad; p=0.006), while between-group differences in 52 
changes in phase were not different in response to the cold stress (interaction term: p=0.06).  53 
Conclusions: This pilot study suggests that static CA is similar between individuals with cervical 54 
SCI and able-bodied controls in response to moderate increases in MAP, while dynamic CA 55 
may be impaired in cervical SCI due to disturbed sympathetic control. 56 
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INTRODUCTION 70 
The precise regulation of cerebral blood flow (CBF) is essential in preventing 71 
unconsciousness and brain damage.1, 2 The capacity of the central vasculature to maintain 72 
CBF by adjusting cerebrovascular resistance over a range of mean arterial pressure (MAP) is 73 
referred to as cerebral autoregulation (CA).3-5 The physiological mechanisms responsible for 74 
CA are not yet clear, but include myogenic (smooth muscle responding to changes in vascular 75 
wall tension), cholinergic, and sympathetic mechanisms.3, 6-11 CA is typically evaluated by 76 
measuring CBF changes in response to a steady-state change in MAP (‘static’ CA), or by 77 
measuring CBF changes in response to transient fluctuations in MAP (‘dynamic’ CA). Static 78 
CA has for example been determined by examining mean CBF changes relative to MAP 79 
changes over two minutes in response to orthostatic stress,12, 13 while dynamic CA is 80 
evaluated commonly using transfer function coherence, gain and phase of spontaneous 81 
changes in MAP and CBF velocity.14, 15 Coherence reflects the linear correlation between 82 
changes in MAP and changes in CBF velocity, gain reflects the magnitude in which a given 83 
change in MAP alters CBF velocity, and phase reflects the time delay between changes in 84 
MAP to be reflected in changes in CBF velocity.14, 15 A higher transfer function gain can be 85 
interpreted as the primary indicator of less adequate dynamic CA, while a higher coherence 86 
and shorter phase may also reflect less adequate dynamic CA.14, 15 Important to note is that 87 
static and dynamic CA represent two experimental approaches for quantifying the relationship 88 
between MAP and CBF velocity over different time scales6 and not necessarily distinct 89 
physiological mechanisms.3  90 
 Whether disruption of central sympathetic control, present in individuals with cervical 91 
spinal cord injury (SCI),16 leads to inadequate CA remains unclear.17-19 An inability to buffer 92 
the frequently occurring periods of high and low MAP caused by impaired sympathetic 93 
control16 may explain why the SCI population is at increased risk of stroke and 94 
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cerebrovascular disease.18, 20, 21 Prior studies indicate that static CA is not different in 95 
participants with chronic cervical SCI compared to able-bodied controls (see 17 for an 96 
overview), while data from able-bodied participants indicates that pharmaceutically-induced 97 
sympathetic blockade has little or no effect on static CA.6, 22 However, each of these studies 98 
tested the capacity to maintain CBF during reductions in MAP, which in able-bodied 99 
individuals exhibits less effective buffering than increases in MAP, a phenomenon called CA 100 
hysteresis.3, 4, 23, 24 Static CA has also been reported to be similar between participants with 101 
SCI and able-bodied controls in response to increases in MAP evoked via the cold pressor 102 
test.25, 26 However, it remains unclear whether this stress elicited peripherally-mediated 103 
sympathetic outflow secondary to autonomic dysreflexia.27-29 Furthermore, prior studies have 104 
largely failed to measure respiratory rate, PaO2 and PaCO2, which can influence interpretation of 105 
CA.15, 30, 31 As such, it has yet to be tested whether static CA is also similar between 106 
individuals with cervical SCI and able-bodied controls in response to moderate increases in 107 
MAP without peripherally-mediated sympathetic outflow and changes in respiratory rate, PaO2 108 
and PaCO2. 109 
The effects of cervical SCI and the role of disturbed sympathetic control of the 110 
cerebrovasculature on dynamic CA are also unclear. A recent study reported that participants 111 
with SCI at or above the 4th thoracic segment had a shorter transfer function phase compared 112 
to able-bodied controls during supine conditions, suggesting that dynamic CA is impaired in 113 
cervical SCI.32 Earlier studies also demonstrated a higher transfer function gain or shorter 114 
phase in participants with cervical SCI compared to able-bodied controls during an orthostatic 115 
challenge that decreased MAP.19, 33 However, transfer function coherence, gain and phase 116 
during a stress that moderately increases MAP has never been studied in individuals with 117 
cervical SCI.  118 
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Therefore, the objective of this pilot study was to characterize static and dynamic CA 119 
of individuals with cervical SCI compared to able-bodied controls in response to a moderate 120 
increase in MAP caused by mild whole-body cold stress, in order to provide insight into the 121 
effect of disturbed central sympathetic control of the cerebrovasculature on CA. We 122 
hypothesized that in response to a moderate increase in MAP 1) static CA would be similar 123 
between the cervical SCI and able-bodied group; and 2) dynamic CA, operationalized by 124 
transfer function coherence, gain and phase, would be different between the cervical SCI and 125 
able-bodied group.   126 
 127 
 128 
METHODS 129 
 130 
Participants 131 
Five otherwise healthy men with C5/C6 lesions (5-26 y post-injury; AIS A: n=4; AIS B: n=1) 132 
participated in the study, along with six healthy age-matched able-bodied men who served as 133 
a control group (Table 1). Resting levels of plasma noradrenaline < 94 pg/mL indicated 134 
autonomic completeness19, 35 (Table 1). In addition, the drop of 19 to 30 mmHg in systolic 135 
blood pressure measured during a sit-up test36 was also suggestive of autonomic 136 
completeness. Two additional participants (SCI: n=1, aged 25 y; able-bodied: n=1, aged 28 y) 137 
were excluded from the study given an unanticipated decrease in MAP during the cold stress 138 
stage (SCI: -7 mmHg; able-bodied: -11 mmHg). 139 
 140 
Procedures 141 
All participants fasted for ≥4 hours before the trial and emptied their bladder upon arrival at 142 
the testing facilities. Participants were tested in a supine position wearing a thin-tubed whole-143 
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body suit (Allen-Vanguard Technologies Inc, Ottawa, Canada) in a laboratory with an 144 
ambient temperature of 27.5-28.60C and 40-45% relative humidity. The water-perfused suit 145 
covered the entire skin surface except for the feet, hands and head.37 Standardized whole-146 
body normothermic conditions at the start of trial were achieved by perfusing 330C water 147 
through the suit for approximately 30 min during instrumentation.37 After this, the total time 148 
of the trial was 60 min, consisting of three consecutive stages: baseline normothermic 149 
conditions (10 min with 330C water through the suit), mild cold stress (20 min with 250C 150 
water) and post-cold recovery (30 min with 330C water). Previous data indicated that 20 min 151 
of cold is the minimal duration to evoke a drop in skin temperature and that 30 min is the 152 
minimum duration required to return skin temperature to normothermic levels.37 The use of 153 
previously established minimum durations was also used to reduce the risk of pressure sores. 154 
To further reduce the risk of pressure sores, participants with cervical SCI were manually 155 
lifted from the table for one minute after each of the instrumentation, baseline, and cold stress 156 
stages. Hemodynamic, body temperature, and respiratory measurements were conducted 157 
continuously throughout the trial, while blood samples for catecholamines were taken three 158 
minutes before the end of each stage.  159 
 160 
Hemodynamic outcomes  161 
Discrete systolic and diastolic blood pressure were measured each minute using an upper-arm 162 
cuff on the right arm (Tango+, SunTech Medical Inc., Morrisville, NC, USA). MAP was 163 
calculated by: diastolic blood pressure plus one-third multiplied by pulse pressure.38 CBF 164 
velocity was measured in the middle carotid artery at 200 Hz using a 2-MHz probe (WAKI, 165 
Atys Médical, Soucieu-en-Jarrest, France) placed over the participant’s temporal window. 166 
The probe was fixed at a constant angle with a custom-made probe holder. The transcranial 167 
Doppler ultrasound sample volume was adjusted to capture the proximal segment of the 168 
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middle carotid artery, after which an optimal signal was obtained by trying different angles 169 
and positions of the probe.22 Beat-by-beat blood pressure was measured at 200 Hz using 170 
finger photoplethysmography (MUB101-50, MediSense Inc., Tokyo, Japan) from a long or 171 
ring finger digit on the left hand. Heart rate was determined using the peak-to-peak intervals 172 
of the beat-by-beat blood pressure signal. Impedance cardiography was used to measure 173 
stroke volume and cardiac output at a sample frequency of 1 Hz (PhysioFlow Lab-1, Manatec 174 
Biomedical, Paris, France).  175 
 176 
Body temperature  177 
Oesophageal temperature was measured at a sample frequency of 2 Hz using a copper-178 
constantan thermocouple (LT6A, Gram Corporation, Saitama, Japan).37 Skin temperature was 179 
collected using a similar sensor at 7 sites: forehead, chest, abdomen, upper arm, lower arm, 180 
thigh and calf.37 Mean skin temperature was calculated based on weighting of each site: 181 
forehead (0.07), chest (0.175), abdomen (0.175), upper arm (0.1), lower arm (0.1), thigh (0.2) 182 
and calf (0.16).39  183 
 184 
Respiratory outcomes  185 
Open-circuit spirometry and mass spectrometry (ARCO-2000, Arco System Inc., Kashiwa, 186 
Japan) were used to measure respiratory rate, PETCO2 and PETO2, which have been shown to be 187 
valid estimators of PaO2 and PaCO2.30    188 
 189 
Catecholamines 190 
Blood samples were analyzed for noradrenaline and adrenaline plasma concentrations using 191 
high-performance liquid chromatography (coefficients of variation computed by analysis of 192 
standards: 8.8% and 7.0%, respectively). 193 
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 194 
Data analysis 195 
Data processing was conducted using Matlab 2015b (Mathworks, Natick, USA). Data over 196 
the last 5 minutes of each condition were selected for further analyses. A different time 197 
window with steady-state body temperature was selected if CBF data contained artifacts.40 198 
Only 4 or 4.5 minutes of artifact-free CBF velocity data was available in some participants 199 
(baseline: n=2; cold: n=1; post-cold: n=1), but this was still considered sufficient.41 The mean 200 
over the selected window was calculated for all outcomes.  201 
 202 
Static and dynamic CA 203 
Static CA was determined as the ratio between mean changes in CBF velocity and MAP 204 
(cm/s/mmHg)4 from baseline to the mild cold stress, and from baseline to the post-cold 205 
recovery. For the spectral power and transfer function outcomes underpinning dynamic CA, 206 
beat-to-beat MAP and CBF velocity were obtained by integrating the respective signals 207 
within each cardiac cycle. Cardiac cycles were determined based on the diastolic (nadir-to-208 
nadir) intervals of the beat-by-beat blood pressure signal. Beat-to-beat MAP and CBF velocity 209 
were first linearly interpolated and resampled at 2 Hz and then detrended by subtracting their 210 
3rd order polynomial.15, 22 Subsequently, the beat-to-beat time series were used for spectral and 211 
transfer function analyses based on the Welch algorithm.15 Each time series was subdivided 212 
into successive 256-point Hann windows that overlapped by 50% before fast Fourier 213 
transform analysis.14, 15 This resulted in a spectral resolution of 0.0020 Hz in all but two 214 
participants (0.0039 Hz). The cross-spectrum between MAP (input) and CBF velocity 215 
(output) was determined and divided by the MAP autospectrum to derive the transfer function 216 
coherence, gain and phase.15 Spectral power of MAP and CBF velocity as well as coherence, 217 
gain and phase were averaged over the previously established 0.07-0.20 Hz low-frequency 218 
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bandwidth,15 which is considered to be the primary bandwidth representing sympathetic 219 
influences on the vasculature.42 The contribution of gain and phase toward the band average 220 
was weighted according to their individual precision, which depended on coherence at each 221 
spectral frequency.14 222 
 223 
Statistical analyses 224 
A previous study found significant differences between an able-bodied (n=7) vs a cervical 225 
SCI group (n=4) in transfer function gain during supine conditions (1.1±0.1 vs. 1.5±0.1 226 
mm/s/mmHg, respectively).19 These data were used in G*Power 3.1.9.3 for Mac OS X43 to 227 
estimate that sample sizes of N≥5 (able-bodied) and N≥3 (cervical SCI), based on 95% 228 
power, are required to detect mean differences in transfer function gain of 0.4 cm/s/mm Hg, 229 
using a two-tailed test with α=0.05. The mean and 95% confidence interval (CI) of the 230 
difference was calculated for each within and between-group comparison. In addition, 231 
parametric statistics were applied to all outcome measures with a normal distribution, which 232 
was assessed using Shapiro-Wilks tests (p<0.05). Data were log-transformed if the Shapiro-233 
Wilk test indicated a non-normal distribution. Comparison of baseline characteristics between 234 
the able-bodied and cervical SCI group were conducted using unpaired two-tailed Student t-235 
tests. Hemodynamic, body temperature, respiratory and catecholamine responses from 236 
baseline to mild cold stress and post-cold recovery within and between the able-bodied and 237 
cervical SCI group were assessed using 2 x 3 repeated measures ANOVA. Between-group 238 
comparisons of static and dynamic CA outcomes were conducted using unpaired two-tailed 239 
Student t-tests. The interaction term of 2 x 3 ANOVA was used to assess whether responses 240 
in transfer function coherence, gain and phase to mild cold stress and post-cold recovery were 241 
different between the able-bodied and cervical SCI group. The significance level was set at 242 
p<0.05. Analyses were conducted using SPSS Statistics v22 (SPSS Inc., Chicago, USA). 243 
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 250 
RESULTS 251 
 252 
Baseline characteristics 253 
Table 1 presents all between-group comparisons of baseline characteristics. Lower heart rate 254 
(p=0.03), noradrenaline (p=0.001) and adrenaline (p<.001) outcomes were found in the 255 
cervical SCI compared to the able-bodied group. No between-group differences were 256 
observed in the other hemodynamic (p=0.20-0.99), body temperature (p=0.37-0.98), 257 
respiratory (p=0.19-0.66), and spectral power outcomes (p=0.07-0.61) at baseline.  258 
 259 
Responses to mild whole-body cold stress 260 
Table 2 presents all within-group responses during and following exposure to the mild cold 261 
stress. Hemodynamic responses were similar in both groups (interaction terms: p=0.12-0.91). 262 
An increase in MAP was found in the groups from baseline to cold and post-cold (main effect 263 
of time: p=0.001). Heart rate decreased in both groups from baseline to cold (main effect of 264 
time: p=0.02), leading to a decrease in cardiac output (main effect of time: p=0.02). Body 265 
temperature responses were also similar in both groups (interaction terms: p=0.21-0.27). 266 
Mean skin temperature decreased during the cold stage (main effect of time: p<.001) and 267 
returned to baseline levels during the post-cold stage. Oesophageal temperature was stable 268 
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from baseline to cold, but decreased during the post-cold stage (main effect of time: p<.001). 269 
Respiratory outcomes were stable in both groups (main effects of time: p=0.57-0.97; 270 
interaction terms: p=0.33-0.91), indicating that these outcomes did not confound the 271 
interpretation of static or dynamic CA results (see below). For catecholamines, the increases 272 
in noradrenaline in the able-bodied group during cold and post-cold recovery differed from 273 
the stable noradrenaline levels observed in the cervical SCI group (main effect of time: 274 
p<.001; interaction term: p<.001), in contrast to the responses observed in adrenaline (main 275 
effect of time: p=0.06; interaction term: p=0.09). In the spectral outcomes, no differences 276 
were observed in the groups for low-frequency power of MAP or CBF velocity (main effect 277 
of time: p=0.15 and 0.80; interaction terms: p=0.10 and 0.15, respectively).  278 
 279 
Static CA  280 
In both groups, only small or no changes in CBF velocity were observed during and following 281 
exposure to the mild cold stress when faced with the increases in MAP (Table 2). As such, no 282 
differences in static CA were observed for the cold stress when the able-bodied group 283 
(mean±SD: 0±2 cm/s/mmHg) and cervical SCI group (mean±SD: 4±8 cm/s/mmHg) were 284 
compared (mean [95% CI] of between-group difference: -4 [-11 to 3] cm/s/mmHg; p=0.24). 285 
Also for the post-cold recovery, no differences in static CA were observed when the able-286 
bodied group (mean±SD: 0±1 cm/s/mmHg) and cervical SCI group (mean±SD: 2±3 287 
cm/s/mmHg) were compared (mean [95% CI] of between-group difference: -2 [-5 to 1] 288 
cm/s/mmHg; p=0.22). 289 
 290 
Dynamic CA 291 
Table 3 presents the between-group comparisons of transfer function outcomes at baseline. 292 
For dynamic CA at baseline, transfer function in the cervical SCI group demonstrated a 293 
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shorter phase (p=0.006) but no difference in coherence (p=0.40) or gain (p=0.08) when 294 
compared to the able-bodied group. Figure 1 presents the responses in transfer function 295 
outcomes during and following exposure to the mild cold stress. When compared to baseline, 296 
smaller or no between-group differences in phase were observed during cold (mean [95% CI]: 297 
0.4 [0.0 to 0.7] rad; p=0.04) and post-cold recovery (mean [95% CI]: 0.2 [-0.1 to 0.5] rad; 298 
p=0.15). However, the responses in phase were not different between the groups when 299 
analyzed using 2 x 3 ANOVA (interaction term: p=0.06). Responses between the groups were 300 
also not different for coherence (interaction term: p=0.07) or gain (interaction term: p=0.41). 301 
 302 
DISCUSSION 303 
This pilot study is the first to characterize static and dynamic CA in individuals with cervical 304 
SCI using a moderate increase in MAP caused by mild-whole body cold stress. Importantly, 305 
this intervention evoked a moderate increase in MAP without signs of peripherally-mediated 306 
sympathetic outflow or changes in respiratory rate, PaO2 and PaCO2. These preliminary data 307 
suggest that static CA in response to moderate increases in MAP was similar between the 308 
cervical SCI and able-bodied group. In contrast, the shorter transfer function phase between 309 
spontaneous changes in CBF velocity and MAP in the cervical SCI group suggests that 310 
dynamic CA was impaired in the cervical SCI group. Furthermore, smaller between-group 311 
differences in transfer function phase were observed when MAP was increased in response to 312 
the mild cold stress.  313 
The findings on static CA in response to an increase in MAP are similar to other 314 
studies that showed adequate static CA in individuals with chronic cervical SCI compared to 315 
able-bodied controls using an orthostatic challenge to decrease MAP (see 17 for an overview). 316 
Comparable measures of static CA were also observed in SCI and able-bodied individuals 317 
during cold pressor tests and periods of autonomic dysreflexia.25, 26, 29 Our pilot data extend 318 
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those findings by showing similar static CA during moderate MAP increases without signs of 319 
peripherally-mediated increases in sympathetic outflow or changes in respiratory rate, PaO2 and 320 
PaCO2.  Taken together, these results suggest that central sympathetic control is not a 321 
prerequisite for static CA, in line with findings of the largely unaffected static CA after 322 
pharmaceutically-induced sympathetic blockade in able-bodied participants.6, 22  323 
In contrast to static CA, differences between the SCI and able-bodied group were found 324 
in transfer function phase based on spontaneous changes in MAP and CBF velocity during 325 
normothermic supine baseline conditions, suggesting that sympathetic control is required for 326 
optimal dynamic CA.6 The focus on static CA in older studies could explain why it was 327 
traditionally thought that sympathetic mechanisms had no role in CA.6, 9, 11, 44 A shortened 328 
transfer function phase in participants with cervical SCI compared to able-bodied controls, along 329 
with an absence of differences in transfer function coherence and gain, were also found in a 330 
recent, larger study during supine baseline conditions.32 The mean between-group difference in 331 
phase in that study of 0.2 rad (95% CI of the difference not reported) was somewhat smaller than 332 
the mean of 0.6 rad (95% CI: 0.2 to 1.0) in our study. This size difference may be attributed to the 333 
inclusion in the prior study of participants with lesions at or the 4th thoracic segment,32 who may 334 
have had more sympathetic control than the participants with cervical SCI included in our study.16 335 
Our findings are strengthened by rigorous artifact checking,40 and the use of weighting based 336 
on coherence level when averaging phase and gain over a spectral frequency bandwidth.14 337 
This method is considered to minimize risk of bias inherent to low coherence.14 Not using this 338 
method might explain why previous studies found no significant differences in phase between 339 
able-bodied and cervical SCI groups during supine conditions.19, 33, 34 Taken together, the 340 
shortened transfer function phase found in the recent larger study,32 along with ours, suggest 341 
that intact central sympathetic control is a prerequisite for optimal dynamic CA, providing 342 
insights that can inform the ongoing debate about the role of sympathetic control for CA.3, 9, 11  343 
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Besides disturbed central sympathetic control, another explanation for suboptimal CA 344 
could be the low resting blood pressure commonly occurring in individuals with cervical 345 
SCI.16, 32 Recent data indicate that CA of healthy, able-bodied men is better adapted to 346 
compensate for transient hypertension than transient hypotension.3, 4, 23, 24 It could be that 347 
human CA is also less effective at compensating for chronic hypotension than chronic 348 
hypertension due to reduced cerebral perfusion pressure caused by lower resting blood 349 
pressure.32 A role of low resting blood pressures influencing dynamic CA in cervical SCI may 350 
also explain the smaller between-group difference in transfer function phase observed during 351 
the moderate increase in MAP caused by the mild cold stress, although this remains 352 
speculative given that responses in dynamic CA were not significantly different between the 353 
groups (Figure 1). A longer phase could imply that the cerebrovasculature has more time to 354 
respond to transient changes in MAP using mechanisms other than sympathetic control, such 355 
as myogenic factors.3, 6, 7  356 
Given the absence of signs of peripherally-mediated sympathetic outflow or changes 357 
in respiratory rate, PaO2 and PaCO2, mild whole-body mild cold stress seems an appropriate 358 
intervention for studying the role of the disturbed central sympathetic control in cervical SCI. 359 
Not anticipated was that MAP was still significantly increased in both groups during the post-360 
cold stage. Even though mean skin temperature returned to baseline levels during the post-361 
cold stage, MAP was still significantly increased in the cervical SCI as well as the able-362 
bodied group. It seems the stressor was sufficient to maintain MAP at levels similar to the 363 
cold stage, even 30 minutes after cessation of the stressor.  364 
 365 
Study limitations 366 
The assumption of indexing CBF using transcranial Doppler ultrasound is that the cross-367 
sectional diameter of the insonated vessel is unchanged; CBF velocity is then proportional to 368 
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CBF.3 Although this assumption can be violated,46 various studies have shown that changes in 369 
middle cerebral artery diameter are unlikely during resting conditions without extreme 370 
changes in MAP.47 The moderate changes in MAP independent of a change in respiratory 371 
outcomes observed in our study further strengthen the likelihood against a change in vessel 372 
diameter. The goal of the present study was to compare each participant against their own 373 
normothermic baseline. However, in this design, we cannot exclude the possibility that the 374 
observed changes in the cervical SCI group were influenced by normal variations over time or 375 
measurement error. These risks were reduced in our study by the post-cold measurements 376 
demonstrating a return to baseline values in most outcomes, along with the previously 377 
reported reliability of dynamic CA metrics during supine conditions,48, 49 which was further 378 
enhanced by the use of rigorous artifact checking40 and use of weighting based on coherence 379 
level.14 Finally, unconscious bias due to the unblind nature of the present protocol cannot be 380 
excluded. To reduce such risk, all data analyses were conducted by one author (JWvdS) and 381 
independently verified by another author (YK). 382 
 383 
Recommendations for future research 384 
Our data suggest the need for better understanding if and how inadequate dynamic CA is 385 
influencing the increased risk of stroke and other cerebrovascular conditions of individuals 386 
with CSCI.18, 20, 21 Longitudinal studies are needed to understand if and what adaptations in 387 
static and dynamic CA13, 17 occur from the acute to chronic post-injury stages. Mild whole-388 
body mild cold stress seems an appropriate intervention for further studying the role of the 389 
disturbed central sympathetic control in cervical SCI. An intervention with a longer post-cold 390 
recovery could provide further insight into the responses of CA outcomes when MAP returns 391 
to baseline after mild cold stress. Measurement of the posterior carotid artery, in addition the 392 
middle carotid artery, may elucidate if these vessels respond differently to increases in MAP 393 
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caused by mild cold stress.30, 33 Future research on quantification of dynamic CA in 394 
individuals with cervical SCI should ideally be expanded to non-linear relationships in 395 
addition to the linear relationships examined using transfer function analyses.50, 51 Finally, 396 
individual data of this study should be used in a future meta-analysis regarding transfer 397 
function in cervical SCI compared to able-bodied groups. Not only can these research angles 398 
further elucidate the still debated role of the sympathetic nervous system as a mechanism 399 
contributing to CA in humans,3, 9, 11 but they may also help reduce the risk of stroke and 400 
cerebrovascular disease of individuals with cervical SCI.18, 20, 21   401 
 402 
Conclusions 403 
This pilot study suggests that in response to a moderate increase in MAP using mild cold stress, 404 
static CA is similar in individuals with cervical SCI compared to able-bodied controls. In 405 
contrast, our preliminary data suggest that dynamic CA may be impaired in individuals with 406 
cervical SCI compared to able-bodied controls due to disturbed central sympathetic control over 407 
the cerebrovasculature and/or due to the indirect result of reduced cerebral perfusion pressure 408 
caused by lower resting blood pressure.  409 
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Titles and legends to Figures 420 
 421 
Figure 1. Mean and SD of transfer function coherence, gain and phase at baseline during and 422 
following exposure to mild whole-body cold stress in the cervical SCI (n=5) and able-bodied 423 
group (n=6). P-values represent the interaction terms of 2 x 3 repeated measures ANOVA. 424 425 
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Table 1. Baseline participant characteristics in the able-bodied compared to the cervical spinal cord injury 611 
group.  612 
 Able-bodied 
(n=6) 
Cervical SCI 
(n=5) 
Able-bodied vs. cervical 
SCI 
 Mean±SD Mean±SD Mean (95% CI) difference 
Demographics/anthropometrics    
Age (y) 40±15 36±9 4 (-13 to 21) 
Height (m) 174±6 178±9 -5 (-15 to 5) 
Body weight (kg) 67±6 63±15 4 (-12 to 19) 
Hemodynamic     
MAP (mm Hg) 85±8 79±9 6 (-6 to 17) 
CBF velocity (cm/s) 63±12 67±20 -4 (-25 to 18) 
Heart rate (b/min) 70±11 56±6 15 (2 to 27)* 
Stroke volume (mL) 77±8 77±17 0 (-17 to 17) 
Cardiac output (L/min) 5.5±1.0 4.6±1.3 0.9 (-0.6 to 2.5) 
Body temperature     
Mean skin temperature (0C) 34.9±0.6 34.6±0.6 0.3 (-0.5 to 1.1) 
Oesophageal temperature (0C) 36.7±0.2 36.7±0.6 0.0 (-0.6 to 0.5) 
Respiratory     
End-tidal PCO2 (mm Hg) 39±3 38±2 -2 (-2 to 6) 
End-tidal PO2 (mm Hg) 106±2 109±5 -3 (-8 to 2) 
Respiratory rate (Hz) 0.25±0.07 0.27±0.09 -0.02 (-0.13 to 0.09) 
Catecholamines    
Noradrenaline 228±80 56±30 172 (85 to 258)** 
Adrenaline 37±11 7±4 30 (18 to 42)*** 
Spectral power    
Power MAP (mm Hg2/Hz) 21±20 2±1 -18 (-1 to -34) 
Power CBF velocity 
([cm/sec]2/Hz)a 
17±27  10±13  -7 (-31 to 18) 
MAP = mean arterial pressure; SCI = spinal cord injury; CBF = cerebral blood flow 613 
*p<0.05; **p<0.01; ***p<0.001 in unpaired two-tailed Student t-tests 614 
a Tested after log transform, as data were not normally distributed. 615 
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Table 2. Within-group responses in hemodynamic, body temperature, respiratory, catecholamine, and spectral outcomes during and following exposure to 616 
mild whole-body cold stress. 617 
 Able-bodied (n=6) Cervical SCI (n=5) 
 Δ Baseline to cold Δ Baseline to post-cold Δ Baseline to cold Δ Baseline to post-cold 
 Mean±SD (95% CI) Mean±SD (95% CI) Mean±SD (95% CI) Mean±SD (95% CI) 
Hemodynamic     
MAP upper-arm cuff (mm Hg)** 5±3 (2 to 7) 6±4 (2 to 9) 7±7 (-2 to 16) 10±8 (1 to 20) 
CBF velocity (cm/s) 1±6 (-6 to 7) 1±5 (-5 to 7) 1±7 (-7 to 10) 2±2 (0 to 5) 
Heart rate (beats/min)* -3±3 (-6 to 0) 0±3 (-3 to 4) -1±1 (-3 to 0) 0±3 (-4 to 4) 
Stroke volume (mL) 0±3 (-3 to 3) 0±5 (-4 to 4)a 1±3 (-3 to 4) -3±7 (0 to -6) 
Cardiac output (L/min)* -0.4±0.3 (-0.7 to 0.0) -0.1±0.3 (-0.5 to 0.2)a -0.2±0.2 (-0.4 to 0.1) -0.4±0.4 (-0.1 to -0.7) 
Body temperature     
Mean skin temperature (0C)*** -1.7±0.5 (-2.2 to -1.2) -0.4±0.6 (-1.1 to 0.2) -2.1±0.3 (-2.5 to -1.7) -0.4±0.6 (-1.1 to 0.4) 
Oesophageal temperature (0C)*** 0.0±0.1 (-0.1 to 0.1) -0.2±0.1 (-0.3 to 0.0) -0.1±0.1 (-0.2 to 0.0) -0.3±0.2 (-0.5 to -0.1) 
Respiratory     
End-tidal PCO2 (mm Hg) 1±1 (0 to 2) 0±1 (-1 to 0) 0±2 (-3 to 2) 0±0 (-2 to 1) 
End-tidal PO2 (mm Hg) 0±2 (-2 to 2) 0±2 (-2 to 2) 0±5 (-5 to 6) 0±3 (-4 to 3) 
Respiratory rate (Hz) 0.01±0.04 (-0.03 to 0.05) 0.02±0.03 (-0.02 to 0.05) 0.00±0.02 (-0.03 to 0.03) -0.01±0.03 (-0.05 to 0.03) 
Catecholamines     
Noradrenaline***# 47±81 (-38 to 133) 183±72 (108 to 258) -1±21 (-27 to 25) 21±17 (-1 to 43) 
Adrenaline -5±9 (-14 to 4) 13±22 (-10 to 36) 0±0 (0 to 0) 1±2 (-1 to 3) 
Spectral power     
Power MAP (mm Hg2/Hz) 6.2±8.4 (-2.6 to 15.1) 1.4±3.6 (-2.5 to 5.2) 0.0±1.0 (-1.2 to 1.3) 1.2±1.0 (-0.1 to 2.4) 
Power CBF velocity ([cm/sec]2/Hz)b 0.7±5.8 (-5.3 to 6.8) -2.3±10.0 (-12.8 to 8.2) 1.1±3.0 (-2.6 to 4.8) 4.7±4.4 (-0.8 to 10.2) 
MAP = mean arterial pressure; CSCI = cervical spinal cord injury; CBF = cerebral blood flow; Δ Cold = cold – baseline; Δ Post-cold = post-cold – baseline 618 
*p<0.05; **p<0.01; ***p<0.001 for main effect of time in 2 x 3 repeated measures ANOVA  619 
# p<0.001 for the interaction term in 2 x 3 repeated measures ANOVA  620 
a Missing data for n=1 621 
b Tested after log transform, as data were not normally distributed 622 
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Table 3. Baseline transfer function outcomes of dynamic cerebral autoregulation in the able-bodied compared 623 
to the cervical spinal cord injury group. 624 
 Able-bodied (n=6) Cervical SCI (n=5) Able-bodied vs. cervical SCI 
 Mean±SD Mean±SD Mean (95% CI) difference 
Coherence (index of 0-1) 0.63±0.08 0.68±0.09 -0.05 (-0.16 to 0.07) 
Gain (cm/s/mmHg) 0.8±0.3 1.7±1.1 -0.9 (-1.9 to 0.1) 
Phase (rad) 0.6±0.3 0.0±0.3 0.6 (0.2-1.0)** 
SCI = cervical spinal cord injury 625 
**p<0.01 626  627  628 
 629 
